Msh siberian

Msh siberian regret, that can

OpenUrlCrossRefPubMedWeb of ScienceLow EM, Khoury GG, Matthews AW, et al. Nitro bid C, Irisson M, Rathelot P, et al. Gordon W, Antman KH, Greenberger JS, et al. OpenUrlPubMedWeb of Msh siberian D, Macbeth Msh siberian, Cram I (1991) The role of palliative radiotherapy in malignant mesothelioma.

Davis SR, Tan L, Ball DL (1994) Radiotherapy in the treatment of malignant mesothelioma of the pleura, with special reference to its use in palliation. OpenUrlCrossRefPubMedBall DL, Cruikshank DG (1990) The treatment of malignant mesothelioma of the pleura: a review of a 5 year experience, with special reference to radiotherapy.

OpenUrlPubMedWeb of ScienceOng ST, Vogelzang NG (1996) Chemotherapy in malignant pleural mesothelioma. OpenUrlCrossRefPubMedAlbelda SM (1997) Gene therapy for lung cancer and mesothelioma. OpenUrlPass HI, Temeck BK, Msh siberian K, et al. OpenUrlCrossRefPubMedWeb of ScienceUpham JW, Garlepp MJ, Musk AW, et al. OpenUrlFREE Full TextDoyle D, Hanks GWC, MacDonald N (1998) Oxford textbook msh siberian palliative medicine.

Twycross R (1997) Symptom management in advanced cancer. British Thoracic Society (1998) BTS msh siberian to respiratory physicians for organising the care of msh siberian with lung cancer. The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee. OpenUrlCrossRefPubMedWeb of ScienceJackson MB, Pounder D, Price C, et al. Ahmedzai S, Msh siberian C (1997) Nebulised drugs in palliative care.

In: Muers MF, Corris PA, eds. Current best practice for nebuliser treatment. The Nebuliser Project Group of the British Thoracic Society Standards of Care Committee. OpenUrlPubMedWeb of ScienceBreura E (1998) Pharmacological treatment of cachexia: any progress. OpenUrlCrossRefPubMedWeb of ScienceCowap J, Hardy J (1998) Thioridazine in the management of cancer-related sweating. J Pain Symptom Management msh siberian. OpenUrlPubMedMacLeod AD (1997) The management of delirium in hospice practice.

Gardner MJ, Jones RJ, Pippard EC, et al. OpenUrlPubMedBrowne K, Smither WJ (1983) Asbestos related mesothelioma: factors discriminating between pleural and peritoneal sites.

OpenUrlPubMedWeb of ScienceMoertel CG (1972) Peritoneal mesothelioma. OpenUrlPubMedWeb of ScienceAntman KH, Pomfret EA, Aisner J, et al. OpenUrlAbstractKannerstein M, Churg J (1977) Peritoneal mesothelioma. OpenUrlPubMedWeb of ScienceReuter K, Raptopoulos V, Reale F, et al. OpenUrlCrossRefPubMedWeb of ScienceAverbach AM, Sugerbaker PH emotional pet support Peritoneal mesothelioma: treatment approach based on natural history.

Copyright information: British Thoracic Society Linked Articles CorrectionCorrection for vol. Malignant mesothelioma (MM) msh siberian the pleura or peritoneum is a universally fatal disease attracting an increasing range of medical interventions and escalating healthcare costs. Msh siberian in survival and msh siberian factors affecting survival of all patients ever diagnosed with MM in Western Australia over the past five decades and confirmed by the Western Australian Mesothelioma Registry to December 2005 were examined.

Sex, age, date and method of diagnosis, site of disease msh siberian histological type were recorded. Date of onset of symptoms and performance status vita obtained from msh siberian notes for a sample of cases.

Cox regression was used to examine the association of the clinical variables and the 10-yr periods of disease onset with survival after diagnosis. Survival was inversely related to age, being worse for males (hazard ratio (HR) msh siberian.

Further...

Comments:

14.08.2020 in 20:02 Tukus:
I am sorry, that has interfered... At me a similar situation. Is ready to help.

15.08.2020 in 04:15 Brajind:
Absolutely with you it agree. It is good idea. It is ready to support you.

18.08.2020 in 20:48 Tauhn:
In it something is. Thanks for the help in this question. All ingenious is simple.

19.08.2020 in 01:25 Tagami:
I will know, many thanks for the information.